Modification of N-Terminal or Side Chain Amino Groups

Need Assistance?

  • US & Canada:
    +
  • UK: +
Modification of N-Terminal or Side Chain Amino Groups

Peptides have good biological activity. However, due to poor stability and other reasons, the application of peptides is relatively limited. By modifying the N-terminus of the peptide, its structure and physicochemical properties can be changed, thereby improving its stability and biological activity. There are many methods for N-terminal modification of peptides, such as acetylation, PEG (polyethylene glycol) modification, and fluorescent reagent modification. The N-terminal amino acid of the peptide can be lysine, cysteine with thiol group, serine, threonine and tyrosine with hydroxyl group, arginine with guanidine group.

  • Formylation

A common feature of formylation of peptides is that the amino terminus (N-terminus) of the peptide sequence is modified by formylation. Formyl peptides are ubiquitous pathogen-related and injury-related molecules. Formyl peptides play important roles in immune defense and regulatory processes.

NameCASSequencePrice
Ac-YVAD-CHO143313-51-3Ac-Tyr-Val-Ala-Asp-alInquiry
Ac-DEVD-CHO169332-60-9Ac-Asp-Glu-Val-Asp-alInquiry
  • 2-Aminobenzoylation (Abz)

2-Aminobenzamide is an organic compound containing fluorescently labeled glycans with free reducing ends, which can be used for non-selective and efficient fluorescent labeling of polysaccharides. 2-Aminobenzoylated peptides can be used as substrate peptides with fluorescent color reaction for the detection of enzymes.

  • Acetylation

The sequence of the peptide generally represents the sequence of the parent protein. Chemically synthesized peptide sequences usually have free amino groups and free carboxyl groups. In order to be closer to the parent protein, the end of the peptide needs to be modified to block. N-terminal acetylation can reduce the overall charge of the peptide, reduce the solubility of the peptide, and also allow the peptide to mimic its original state of alpha amino in the parent protein. The N-terminal acetylation modification of the synthesized polypeptide increases the stability of the peptide and enhances the biological activity of the peptide.

N-terminal acetylationN-terminal acetylation

NameCASSequencePrice
Dermaseptin-like precursor DRP-AC-1BAT-012804GLLSGILNTAGGLLGNLIGSLSNGESInquiry
Dermaseptin-like precursor DRP-AC-2BAT-012805GLLSGILNSAGGLLGNLIGSLSNGESInquiry
Dermaseptin-like precursor DRP-AC-3BAT-012806SVLSTITDMAKAAGRAALNAITGLVNQGEQInquiry
  • Palmitoylation

Palmitoylation modification at the N-terminus of the peptide chain is a common structural modification, and the modified structure can enhance the permeability of the skin layer. Many palmitoylated peptides are useful in the skin care industry.

NameCASSequencePrice
1-Palmitoyl-2-hydroxy-sn-glycero-3-PC17364-16-8Inquiry
Palmitoyl Dipeptide-7911813-90-6palmitoyl-Lys-Thr-OHInquiry
Palmitoyl tetrapeptide-10887140-79-6palmitoyl-Lys-Thr-Phe-Lys-OHInquiry
Palmitoyl Tripeptide-8936544-53-5Inquiry
Palmitoyl hexapeptide-12171263-26-6Pal-VGVAPGInquiry
Palmitoyl pentapeptide-4/Palmitoyl pentapeptide-3214047-00-4palmitoyl-Lys-Thr-Thr-Lys-Ser-OHInquiry
Palmitoyl tripeptide-1147732-56-7palmitoyl-Gly-His-Lys-OHInquiry
Palmitoyl Tripeptide-381447824-23-8Inquiry
Palmitoyl tripeptide-5 triflate623172-56-5palmitoyl-Lys-Val-Lys-OH.2TFAInquiry
Palmitoyl Tetrapeptide-3221227-05-0Palm-Gly-Gln-Pro-ArgInquiry
Palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ala-Gly-OH117858-54-5palmitoyl-Cys(Unk)-Ala-Gly-OHInquiry
  • Myristoylation

Acylation of the N-terminus with fatty acids allows peptides or proteins to bind to cell membranes. Myristic acid can be attached to the N-terminus of the resin-peptide using standard coupling reactions, and the resulting lipopeptide can be cleaved under standard conditions and purified by RP-HPLC.

  • Biotinylation

Biotinylated peptides are commonly used in immunoassays, histocytochemistry and fluorescence-based flow cytometry. Labeled anti-biotin antibodies can also be used to bind biotinylated peptides. During Fmoc solid-phase synthesis, biotin can be attached to the lysine side chain or the N-terminus. 6-aminocaproic acid was used as a link between the peptide and biotin. Links can bind substrates flexibly and bind better in the presence of steric hindrance.

NameCASSequencePrice
Biotinyl-(Arg8)-Vasopressin126703-17-1Biotinyl-CYFQNCPRG-NH2 (Disulfide bridge: Cys1-Cys6)Inquiry
Biotinyl-Somatostatin-14145251-83-8Biotinyl-AGCKNFFWKTFTSC (Disulfide bridge: Cys3-Cys14)Inquiry
Biotin-VAD-FMK1135688-15-1Biotin-Val-Ala-Asp(OMe)-FMKInquiry
Biotinyl-α-CGRP (human)1816258-60-2Biotinyl-ACDTATCVTHRLAGLLSRSGGVVKNNFVPTNVGSKAF-NH2 (Disulfide bridge: Cys2-Cys7)Inquiry
Biotinyl-α-CGRP (mouse, rat)1816258-61-3Biotinyl-SCNTATCVTHRLAGLLSRSGGVVKDNFVPTNVGSEAF-NH2 (Disulfide bridge: Cys2-Cys7)Inquiry
Biotin-NHS35013-72-0Inquiry
Biotinyl-BNP-32 (human)1816258-27-1Biotinyl-SPKMVQGSGCFGRKMDRISSSSGLGCKVLRRH (Disulfide bridge: Cys10-Cys26)Inquiry
Biotinyl-pTH (1-34) (human)213779-14-7Inquiry
Biotinyl-Hepcidin-25 (human)1815618-07-5Biotinyl-DTHFPICIFCCGCCHRSKCGMCCKT (Disulfide bridge: Cys7-Cys23, Cys10-Cys13, Cys11-Cys19, Cys14-Cys22)Inquiry
Biotinyl-KR-12 (human)2022956-47-2Biotin-KRIVQRIKDFLRInquiry
Biotinyl-LL-372243219-80-7Biotinyl-LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTESInquiry
Biotinyl-ACTH (1-39) (human)1816258-26-0Biotinyl-SYSMEHFRWGKPVGKKRRPVKVYPNGAEDESAEAFPLEFInquiry
Biotinyl-Amylin (mouse, rat)1678414-88-4Biotinyl-KCNTATCATQRLANFLVRSSNNLGPVLPPTNVGSNTY-NH2 (Disulfide bridge: Cys2-Cys7)Inquiry
Biotin-TAT (47-57)1231898-25-1Biotin-YGRKKRRQRRRInquiry
Biotinoyl tripeptide-1299157-54-3biotinyl-Gly-His-Lys-OHInquiry
(Biotinyl-Gln1)-LHRH218433-98-8Biotinyl-QHWSYGLRPG-NH2Inquiry
  • Hynic Modification

HYNIC (hydrazine imide) is a highly efficient chelating agent that offers the possibility for efficient and localized modification of biomolecular imaging.

NameCASSequencePrice
Hynic-Toc Trifluoroacetate257943-19-4FC(1)YWKTC(1)TInquiry
  • DOTA Modification

DOTA is a bifunctional chelating agent with high thermodynamic and kinetic stability. DOTA bifunctional chelating agent contains two reactive groups at the same time, one of which can react with amino groups in peptides and proteins to form stable covalent bonds, and the other reactive group reacts with metal nuclides (such as lanthanum) system) to form stable complexes.

NameCASSequencePrice
DOTA(allyl ester)3BAT-014798Inquiry
DOTA-tris(tert-butyl ester)137076-54-1BAT-009048Inquiry
DOTA-[Tyr3]-Octreotide Acid177943-89-4BAT-010211Inquiry
  • DOPA Modification

DOPA can be used to modify proteins, peptides and other materials with reactive groups. There is a synergistic adsorption effect between DOPA and the positive charge of lysine.

  • Trifluoroacetylation (TFA)

Trifluoroacetyl (TFA) has excellent protective effect on hydroxyl and amino groups, and has a very important application in the synthesis of amino acids and polypeptide compounds. TFA can be introduced into the peptide sequence with trifluoroacetic anhydride and can be easily removed in dilute lye. TFA-protected amino acids or peptides are readily vaporized under high vacuum and can be used in gas chromatography to detect the degree of racemization and to determine the sequence of native peptides. The purity, degree of racemization, etc. of the trifluoroacetyl-modified peptide can be detected by 19F NMR.

NameCASSequencePrice
TFLLR-NH2(TFA)1313730-19-6Thr-Phe-Leu-Leu-ArgInquiry
PAR-4 Agonist Peptide, amide TFA1228078-65-6Ala-Tyr-Pro-Gly-Lys-PheInquiry
BIBP 3226 TFA1068148-47-9Inquiry
Cilengitide TFA salt199807-35-7cyclo[Arg-Gly-Asp-D-Phe-N(Me)Val].TFAInquiry
Arg-Gly-Asp TFA salt2378808-45-6Arg-Gly-AspInquiry
Peptide T TFA1610056-01-3ASTTTNYT.TFAInquiry
OVA Peptide (257-264) TFA1262751-08-5SIINFEKL.TFAInquiry
ACTH (18-39), human TFA73724-75-1RPVKVYPNGAEDESAEAFPLEF.TFAInquiry
Elamipretide TFA1606994-55-1D-Arg-Tyr(2,6-diMe)-Lys-Phe-NH2.TFAInquiry
Neurokinin B TFA101536-55-4DMHDFFVGLM-NH2.TFAInquiry
D-Ala-D-Leu-OH TFA1820579-48-3Ala-LeuInquiry
H-Glu-Thr-Tyr-Ser-Lys-OH 2 TFA300584-91-2H-Glu-Thr-Tyr-Ser-Lys-OHInquiry
Z-Tyr-Lys-Arg-pNA 2 TFA108318-36-1Z-Tyr-Lys-Arg-pNAInquiry
MeOSuc-Ala-Phe-Lys-AMC.TFA201853-92-1MeOSuc-Ala-Phe-Lys-AMCInquiry

Online Inquiry

Verification code
Inquiry Basket